Barbara C. Vanderhyden

ORCID: 0000-0002-7644-7189 · 4 papers in corpus
other 2022
International journal of molecular sciences ·doi:10.3390/ijms232314608

Natural Killer (NK) cell cytotoxicity and interferon-gamma (IFNγ) production are profoundly suppressed postoperatively. This dysfunction is associated with increased morbidity and cancer recurrence. NK activity depends on the integration of…

lab-animal 2019
International journal of molecular sciences ·doi:10.3390/ijms20092264

Epithelial ovarian cancer (EOC) represents the most lethal gynecologic malignancy; a better understanding of the molecular mechanisms associated with EOC etiology could substantially improve EOC management. Aberrant O-glycosylation in cance…

lab-animal 2018
Oncogene ·doi:10.1038/s41388-018-0377-y

Estrogenic hormone replacement therapy increases the risk of developing ovarian cancer, and estrogen promotes tumour initiation and growth in mouse models of this disease. GREB1 (Growth regulation by estrogen in breast cancer 1) is an ESR1 …

lab-animal 2013
Biology of reproduction ·doi:10.1095/biolreprod.113.111336

Estrogen signaling in the ovary is a fundamental component of normal ovarian function, and evidence also indicates that excessive estrogen is a risk factor for ovarian cancer. We have previously demonstrated that the gonadally enriched TFII…